Targeted novel therapies in Washington, Virginia

Ami A. Chitalia, MD is a board-certified physician specializing in Internal Medicine, Hospice and Palliative Medicine, Medical Oncology, and Hematology. Located at 110 Irving Street Northwest in Washington, DC, Dr. Chitalia is a member of the American Society of Hematology and the American Society of Clinical Oncology. She focuses on treating breast cancer using chemotherapy, endocrine therapy, and targeted novel therapies through clinical trials. Dr. Chitalia also specializes in symptom management and setting goals of care for patients with advanced or complex diagnoses. Her research interests include health disparities in breast cancer treatment and curriculum development for palliative care in oncology. Dr. Chitalia received her medical degree from Tufts University School of Medicine and completed her training at MedStar Georgetown University Hospital and Mount Sinai Hospital. She is now a staff physician at MedStar Washington Cancer Institute, where she provides comprehensive care for her patients. Dr. Chitalia's philosophy of care emphasizes treating the patient as a whole and involving them in decision-making about their treatment. She accepts most major health insurance plans and is dedicated to providing the best possible care for her patients.

Samah Nassereddine, MD, is an Assistant Professor of Medicine specializing in Hematology & Oncology at the GWU Cancer Center located at 2150 Pennsylvania Avenue Northwest in Washington, DC. Dr. Nassereddine earned her Medical Degree from the Lebanese University School of Medicine and completed her residency in Internal Medicine at the American University Of Beirut Medical Center. She then pursued a three-year residency program in Internal Medicine at the George Washington University School of Medicine. Dr. Nassereddine has a strong background in leukemia research, particularly focusing on myeloid malignancies. She completed a Fellowship in Hematology and Medical Oncology at The George Washington University Medical Center and is boarded in Internal Medicine, with eligibility for Medical Oncology and Hematology.